Clifton NJ 乳腺癌临床试验
12项针对 乳腺癌的研究正在 Clifton及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
招募中3 期
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 距离 7 英里
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
招募中3 期
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 0001), Hackensack · 距离 7 英里
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
招募中3 期
- Hackensack Univ Medical Center (HUMC) ( Site 0007), Hackensack · 距离 7 英里
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
招募中1/2 期
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 距离 7 英里
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
招募中3 期
- John Theurer Ctr-Hackensack UMC, Hackensack · 距离 7 英里
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
招募中2 期
- Hackensack Meridian Health, Hackensack · 距离 7 英里
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
招募中1/2 期
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 距离 7 英里
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
招募中3 期
- Hackensack University Medical Center, Hackensack · 距离 7 英里
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
招募中1 期
- John Theurer Cancer Ctr at Hackensack Univ. Med Ctr., Hackensack · 距离 7 英里
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
招募中3 期
- Hackensack University Medical Center, Hackensack · 距离 7 英里
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
招募中1 期
- Hackensack University Medical Center, Hackensack · 距离 7 英里
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
招募中观察性研究
- John Theurer Cancer Center, Hackensack · 距离 7 英里
其他城市的 乳腺癌试验
- New York City, NY136 项研究
- Houston, TX126 项研究
- Boston, MA112 项研究
- Nashville, TN81 项研究
- Los Angeles, CA73 项研究
- Edison, NJ68 项研究
- St. Louis, MO64 项研究
- Queens, NY64 项研究
- Durham, NC64 项研究
- Chicago, IL59 项研究
- Philadelphia, PA56 项研究
- Dallas, TX55 项研究
Clifton的其他研究
- 非小细胞肺癌24 项研究
- 癌症（所有类型）15 项研究
- 多发性骨髓瘤14 项研究
- 转移性癌症12 项研究
- 急性髓系白血病12 项研究
- 前列腺癌12 项研究
- 卵巢癌11 项研究
- 肺癌10 项研究
- 结直肠癌8 项研究
- 头颈鳞状细胞癌8 项研究
- 子宫内膜癌8 项研究
- 心力衰竭8 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。